Sign In
Buy SYF
$75.04
-0.670 (-0.88%)
At Close: Jun 23, 2026
Baker Hughes, Synchrony Financial And 3 Stocks To Watch Heading Into Monday
09:02am, Monday, 23'rd Jan 2023 Benzinga
With US stock futures trading slightly lower this morning on Monday, some of the stocks that may grab investor focus today are as follows:
Wall Street expects Baker Hughes Company (NASDAQ: BKR) to
Synchrony (SYF) Q4 Earnings and Revenues Surpass Estimates
08:17am, Monday, 23'rd Jan 2023
Synchrony (SYF) delivered earnings and revenue surprises of 12.50% and 1.68%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
Fear & Greed Index Moves To 'Greed' Zone As Nasdaq Record Gains For Third Straight Week
08:11am, Monday, 23'rd Jan 2023 Benzinga
The CNN Money Fear and Greed index moved to the "Greed" zone after US stocks closed higher on Friday.
The Dow Jones and S&P 500 recorded gains on Friday, snapping a three-session losing streak. The Na
Making Sense of the Early Q4 Results: Is An Earnings Cliff Coming?
07:36pm, Friday, 20'th Jan 2023 Zacks Investment Research
By the end of this week, we will have seen quarterly results from about 28% of all S&P 500 members and will have a very good sense of whether the earnings-cliff narrative has started unfolding or been
Making Sense of the Early Q4 Results: Is An Earnings Cliff Coming?
03:48pm, Friday, 20'th Jan 2023
By the end of this week, we will have seen quarterly results from about 28% of all S&P 500 members and will have a very good sense of whether the earnings-cliff narrative has started unfolding or been
Synchrony (SYF) to Post Q4 Earnings: What You Should Know
05:57pm, Thursday, 19'th Jan 2023 Zacks Investment Research
Synchrony's (SYF) fourth-quarter results are likely to reflect higher information processing expenses and lower net interest margins.
Synchrony (SYF) to Post Q4 Earnings: What You Should Know
03:03pm, Thursday, 19'th Jan 2023
Synchrony's (SYF) fourth-quarter results are likely to reflect higher information processing expenses and lower net interest margins.
Earnings Preview: Triumph Financial (TFIN) Q4 Earnings Expected to Decline
03:00pm, Wednesday, 18'th Jan 2023 Zacks Investment Research
Triumph Financial (TFIN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Synchrony Financial: Growth And Fundamental Stability Remains In Harmony
08:43am, Wednesday, 18'th Jan 2023
Synchrony Financial maintains a robust performance, balancing revenue growth and viability. Its fundamental stability is visible in its stellar Balance Sheet.
Earnings Preview: Synchrony (SYF) Q4 Earnings Expected to Decline
03:00pm, Monday, 16'th Jan 2023 Zacks Investment Research
Synchrony (SYF) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Synchrony (SYF) to Offer Financing Options at Bassett's Stores
03:03pm, Friday, 13'th Jan 2023 Zacks Investment Research
Synchrony (SYF) aims to extend promotional financing options to customers visiting Bassett Furniture stores and also engage in data sharing with the latter.
Should First Trust Large Cap Value AlphaDEX ETF (FTA) Be on Your Investing Radar?
11:20am, Monday, 09'th Jan 2023 Zacks Investment Research
Style Box ETF report for FTA
Benzinga's Top Ratings Upgrades, Downgrades For January 6, 2023
03:00pm, Friday, 06'th Jan 2023 Benzinga
Upgrades
Piper Sandler upgraded the previous rating for Aligos Therapeutics Inc (NASDAQ:ALGS) from Neutral to Overweight. Aligos Therapeutics earned $0.44 in the third quarter, compared to $0.78 in th
Synchrony (SYF) Up 16% in 6 Months: More Room to Run?
04:16pm, Thursday, 29'th Dec 2022 Zacks Investment Research
Synchrony (SYF) is well-poised to gain on several growth initiatives, a strong CareCredit platform and prudent capital deployment efforts.
Synchrony (SYF) Up 16% in 6 Months: More Room to Run?
12:47pm, Thursday, 29'th Dec 2022
Synchrony (SYF) is well-poised to gain on several growth initiatives, a strong CareCredit platform and prudent capital deployment efforts.
